Advertisement

Topics

Numis Securities Limited Company Profile

08:29 EST 15th December 2018 | BioPortfolio

Numis Securities Limited ("Numis") is a rapidly growing investment banking and institutional stockbroking business providing a premium service to corporate and institutional clients. It is the trading subsidiary of Numis Corporation Plc, whose shares are quoted on the Alternative Investment Market of the London Stock Exchange Our aim is to provide a premium service to our corporate and institutional clients. We do not provide services to individual private customers.
Our services are research driven and concentrate on UK market sectors in which we have proven expertise. They comprise a full range of Corporate Finance, Institutional Stockbroking, Market Making and Research services. As well as our head office in Cheapside in the City of London we are represented in Liverpool, where our analysts and specialist sales team covering the Consumer sector are located and where part of our Speciality Financials expertise can be found

Location

Cheapside House138 Cheapside
London
London
EC2V 6LH
United Kingdom

Contact

Phone: 020 7776 1500


News Articles [214 Associated News Articles listed on BioPortfolio]

Numis Securities cuts Indivior to ‘hold’ from ‘buy’ on effects of copycat drug on sales and profits

Numis’s analysts said: “We now expect significant further downgrades to FY18 EPS (c.20) with US$25mln of cost savings targeted and substantial downgrades to FY19 forecasts c.50% … on the slower ...

Numis Securities cuts Indivior to ‘hold’ from ‘buy’ in the wake of copycat drug impact sales and profit warning

Numis’s analysts said: “We now expect significant further downgrades to FY18 EPS (c.20) with US$25mln of cost savings targeted and substantial downgrades to FY19 forecasts c.50% … on the slower ...

Numis upgrades DS Smith to ‘add’ as packaging group accelerates earnings momentum

In a note to clients, analysts at Numis said the proposed acquisition of Spanish Europac for an enterprise value of €1.9bn will strengthen Iberian and French market presence

Indivior's dive puts it into buying territory, Numis believes

In the last six weeks or so, the share price of Indivior has plunged from 493p to 306p and that's a level at which Numis thinks the upside risk outweighs the downside.

Numis Corporation (NUM) - Investing to underpin future growth

Edison Investment Research - Financials - Numis Corporation: The timing and size of transactions falling into the second half of FY18 has meant that Numis has achieved a record level of revenue but no...

Alliance Pharma spreading its wings in Asia Pacific

Alliance is continuing to build significant growth drivers into its business, Numis Securities asserts. The company's house broker is forecasting 10% revenue growth from 2018 to 2020.

Alliance Pharma building a head of steam in Asia Pacific

Alliance is continuing to build significant growth drivers into its business, Numis Securities asserts. The company's house broker is forecasting 10% revenue growth from 2018 to 2020

Ergomed revenue delay leads to Numis downgrade

The AIM-listed pharmaceuticals developer said the contract delays meant that its first-half revenue was expected to be “below management’s expectations”

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

The human experience of social transformation: Insights from comparative archaeology.

Archaeologists and other scholars have long studied the causes of collapse and other major social transformations and debated how they can be understood. This article instead focuses on the human expe...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Conjugate Vaccine Against Meningococcus C a Brazilian Project

TYPE / DESIGN STUDY: Clinical trial phase II / III, randomized, double-blind, national multi-center, with a total of 1,644 research participants stratified into 3 groups according to age f...

Companies [232 Associated Companies listed on BioPortfolio]

Numis Securities Limited

Numis Securities Limited ("Numis") is a rapidly growing investment banking and institutional stockbroking business providing a premium service to corporate and institutional clients. It is the trading...

Hilltop Securities Inc.

Hilltop Securities Inc., a member of NYSE, FINRA and SIPC, delivers the forthright advice and tailored solutions necessary for municipal issuers, institutions, broker-dealers and ...

Seaview Securities LLC

Seaview Securities LLC is a specialty investment bank assisting life sciences companies with private placements, public offerings, M&A and strategic advice.

Klayman & Toskes, PA

K&T is a leading national securities law firm which practices exclusively in the field of securities arbitration and litigation, on behalf of retail and institutional investors th...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

More Information about "Numis Securities Limited" on BioPortfolio

We have published hundreds of Numis Securities Limited news stories on BioPortfolio along with dozens of Numis Securities Limited Clinical Trials and PubMed Articles about Numis Securities Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Numis Securities Limited Companies in our database. You can also find out about relevant Numis Securities Limited Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record